{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Host-directed antiviral", "Human TMPRSS2", "Human V-ATPase", "Human protein kinase C", "SARS-CoV-2 variants of concern"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36503013", "DateCompleted": {"Year": "2023", "Month": "01", "Day": "17"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "12", "Day": "08"}], "Language": ["eng"], "ELocationID": ["10.1016/j.antiviral.2022.105484", "S0166-3542(22)00253-4"], "Journal": {"ISSN": "1872-9096", "JournalIssue": {"Volume": "209", "PubDate": {"Year": "2023", "Month": "Jan"}}, "Title": "Antiviral research", "ISOAbbreviation": "Antiviral Res"}, "ArticleTitle": "Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics.", "Pagination": {"StartPage": "105484", "MedlinePgn": "105484"}, "Abstract": {"AbstractText": ["The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global public health crisis. The reduced efficacy of therapeutic monoclonal antibodies against emerging SARS-CoV-2 variants of concern (VOCs), such as omicron BA.5 subvariants, has underlined the need to explore a novel spectrum of antivirals that are effective against existing and evolving SARS-CoV-2 VOCs. To address the need for novel therapeutic options, we applied cell-based high-content screening to a library of natural products (NPs) obtained from plants, fungi, bacteria, and marine sponges, which represent a considerable diversity of chemical scaffolds. The antiviral effect of 373 NPs was evaluated using the mNeonGreen (mNG) reporter SARS-CoV-2 virus in a lung epithelial cell line (Calu-3). The screening identified 26 NPs with half-maximal effective concentrations (EC<sub>50</sub>) below 50\u00a0\u03bcM against mNG-SARS-CoV-2; 16 of these had EC<sub>50</sub> values below 10\u00a0\u03bcM and three NPs (holyrine A, alotaketal C, and bafilomycin D) had EC<sub>50</sub> values in the nanomolar range. We demonstrated the pan-SARS-CoV-2 activity of these three lead antivirals against SARS-CoV-2 highly transmissible Omicron subvariants (BA.5, BA.2 and BA.1) and highly pathogenic Delta VOCs in human Calu-3 lung cells. Notably, holyrine A, alotaketal C, and bafilomycin D, are potent nanomolar inhibitors of SARS-CoV-2 Omicron subvariants BA.5 and BA.2. The pan-SARS-CoV-2 activity of alotaketal C [protein kinase C (PKC) activator] and bafilomycin D (V-ATPase inhibitor) suggest that these two NPs are acting as host-directed antivirals (HDAs). Future research should explore whether PKC regulation impacts human susceptibility to and the severity of SARS-CoV-2 infection, and it should confirm the important role of human V-ATPase in the VOC lifecycle. Interestingly, we observed a synergistic action of bafilomycin D and N-0385 (a highly potent inhibitor of human TMPRSS2 protease) against Omicron subvariant BA.2 in human Calu-3 lung cells, which suggests that these two highly potent HDAs are targeting two different mechanisms of SARS-CoV-2 entry. Overall, our study provides insight into the potential of NPs with highly diverse chemical structures as valuable inspirational starting points for developing pan-SARS-CoV-2 therapeutics and for unravelling potential host factors and pathways regulating SARS-CoV-2 VOC infection including emerging omicron BA.5 subvariants."], "CopyrightInformation": "Copyright \u00a9 2022 The Authors. Published by Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada."}], "LastName": "P\u00e9rez-Vargas", "ForeName": "Jimena", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada."}], "LastName": "Shapira", "ForeName": "Tirosh", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada."}], "LastName": "Olmstead", "ForeName": "Andrea D", "Initials": "AD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada."}], "LastName": "Villanueva", "ForeName": "Ivan", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada."}], "LastName": "Thompson", "ForeName": "Connor A H", "Initials": "CAH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada."}], "LastName": "Ennis", "ForeName": "Siobhan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada."}], "LastName": "Gao", "ForeName": "Guang", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada."}], "LastName": "De Guzman", "ForeName": "Joshua", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departments of Chemistry and Earth, Ocean & Atmospheric Science, University of British Columbia, Vancouver, BC V6T 1Z1, Canada."}], "LastName": "Williams", "ForeName": "David E", "Initials": "DE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departments of Chemistry and Earth, Ocean & Atmospheric Science, University of British Columbia, Vancouver, BC V6T 1Z1, Canada."}], "LastName": "Wang", "ForeName": "Meng", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada."}], "LastName": "Chin", "ForeName": "Aaleigha", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada."}], "LastName": "Bautista-S\u00e1nchez", "ForeName": "Diana", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada."}], "LastName": "Agafitei", "ForeName": "Olga", "Initials": "O"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, BC, V5Z 4R4, Canada."}], "LastName": "Levett", "ForeName": "Paul", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, 77555, USA."}], "LastName": "Xie", "ForeName": "Xuping", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bio-Organic Chemistry Unit, Institute of Biomolecular Chemistry, National Research Council, Via Campi Flegrei 34, 80078, Pozzuoli, Italy."}], "LastName": "Nuzzo", "ForeName": "Genoveffa", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Qu\u00edmica de S\u00e3o Carlos, Universidade de S\u00e3o Paulo, CP780, CEP13560-970, S\u00e3o Carlos, SP, Brazil."}], "LastName": "Freire", "ForeName": "Vitor F", "Initials": "VF"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Qu\u00edmica de S\u00e3o Carlos, Universidade de S\u00e3o Paulo, CP780, CEP13560-970, S\u00e3o Carlos, SP, Brazil."}], "LastName": "Quintana-Bulla", "ForeName": "Jairo I", "Initials": "JI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Qu\u00edmica de S\u00e3o Carlos, Universidade de S\u00e3o Paulo, CP780, CEP13560-970, S\u00e3o Carlos, SP, Brazil."}], "LastName": "Bernardi", "ForeName": "Darlon I", "Initials": "DI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Qu\u00edmica de S\u00e3o Carlos, Universidade de S\u00e3o Paulo, CP780, CEP13560-970, S\u00e3o Carlos, SP, Brazil."}], "LastName": "Gubiani", "ForeName": "Juliana R", "Initials": "JR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Chemical Innovation for Sustainability (CIS), School of Science, Mae Fah Luang University, Chiang Rai, 57100, Thailand."}], "LastName": "Suthiphasilp", "ForeName": "Virayu", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Chemical Innovation for Sustainability (CIS), School of Science, Mae Fah Luang University, Chiang Rai, 57100, Thailand."}], "LastName": "Raksat", "ForeName": "Achara", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Chemical Innovation for Sustainability (CIS), School of Science, Mae Fah Luang University, Chiang Rai, 57100, Thailand."}], "LastName": "Meesakul", "ForeName": "Pornphimol", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Chemical Innovation for Sustainability (CIS), School of Science, Mae Fah Luang University, Chiang Rai, 57100, Thailand."}], "LastName": "Polbuppha", "ForeName": "Isaraporn", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Science, University of Phayao, Phayao, 56000, Thailand."}], "LastName": "Cheenpracha", "ForeName": "Sarot", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Medicinal Plants Innovation Center of Mae Fah Luang University, Chiang Rai, 57100, Thailand."}], "LastName": "Jaidee", "ForeName": "Wuttichai", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Unit, Department of Chemistry and Center for Innovation in Chemistry, Faculty of Science, Khon Kaen University, Khon Kaen, 40002, Thailand."}], "LastName": "Kanokmedhakul", "ForeName": "Kwanjai", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Unit, Department of Chemistry and Center for Innovation in Chemistry, Faculty of Science, Khon Kaen University, Khon Kaen, 40002, Thailand."}], "LastName": "Yenjai", "ForeName": "Chavi", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Unit, Department of Chemistry and Center for Innovation in Chemistry, Faculty of Science, Khon Kaen University, Khon Kaen, 40002, Thailand."}], "LastName": "Chaiyosang", "ForeName": "Boonyanoot", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Ci\u00eancias Exatas e Naturais, Universidade Federal de Rondon\u00f3polis, CEP 78736-900, Rondon\u00f3polis, MT, Brazil."}], "LastName": "Teles", "ForeName": "Helder Lopes", "Initials": "HL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bio-Organic Chemistry Unit, Institute of Biomolecular Chemistry, National Research Council, Via Campi Flegrei 34, 80078, Pozzuoli, Italy."}], "LastName": "Manzo", "ForeName": "Emiliano", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bio-Organic Chemistry Unit, Institute of Biomolecular Chemistry, National Research Council, Via Campi Flegrei 34, 80078, Pozzuoli, Italy; Department of Biology, Universit\u00e0 di Napoli \"Federico II\", Via Cupa Nuova Cinthia 21, 80126, Napoli, Italy."}], "LastName": "Fontana", "ForeName": "Angelo", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Universit\u00e9 de Sherbrooke, Sherbrooke, Qu\u00e9bec, J1H 5N4, Canada."}], "LastName": "Leduc", "ForeName": "Richard", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology-Physiology, Faculty of Medicine and Health Sciences, Institut de Pharmacologie de Sherbrooke, Universit\u00e9 de Sherbrooke, Sherbrooke, Qu\u00e9bec, J1H 5N4, Canada."}], "LastName": "Boudreault", "ForeName": "Pierre-Luc", "Initials": "PL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Qu\u00edmica de S\u00e3o Carlos, Universidade de S\u00e3o Paulo, CP780, CEP13560-970, S\u00e3o Carlos, SP, Brazil."}], "LastName": "Berlinck", "ForeName": "Roberto G S", "Initials": "RGS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Chemical Innovation for Sustainability (CIS), School of Science, Mae Fah Luang University, Chiang Rai, 57100, Thailand."}], "LastName": "Laphookhieo", "ForeName": "Surat", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Products Research Unit, Department of Chemistry and Center for Innovation in Chemistry, Faculty of Science, Khon Kaen University, Khon Kaen, 40002, Thailand."}], "LastName": "Kanokmedhakul", "ForeName": "Somdej", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departments of Chemistry and Earth, Ocean & Atmospheric Science, University of British Columbia, Vancouver, BC V6T 1Z1, Canada; The Wistar Institute, Philadelphia, PA, 19104, USA."}], "LastName": "Tietjen", "ForeName": "Ian", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Vancouver Prostate Centre, University of British Columbia, Vancouver, BC V6H 3Z6, Canada."}], "LastName": "Cherkasov", "ForeName": "Artem", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "British Columbia Centre for Disease Control Public Health Laboratory, Vancouver, BC, V5Z 4R4, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada."}], "LastName": "Krajden", "ForeName": "Mel", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cellular and Physiological Sciences, School of Biomedical Engineering, Life Sciences Institute, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada."}], "LastName": "Nabi", "ForeName": "Ivan Robert", "Initials": "IR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, V5A 1S6, Canada."}], "LastName": "Niikura", "ForeName": "Masahiro", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, 77555, USA."}], "LastName": "Shi", "ForeName": "Pei-Yong", "Initials": "PY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departments of Chemistry and Earth, Ocean & Atmospheric Science, University of British Columbia, Vancouver, BC V6T 1Z1, Canada. Electronic address: raymond.andersen@ubc.ca."}], "LastName": "Andersen", "ForeName": "Raymond J", "Initials": "RJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, Life Sciences Institute, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada. Electronic address: fjean@mail.ubc.ca."}], "LastName": "Jean", "ForeName": "Fran\u00e7ois", "Initials": "F"}], "GrantList": [{"GrantID": "U19 AI171413", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "U01 AI151801", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}, {"GrantID": "HHSN272201600013C", "Acronym": "AI", "Agency": "NIAID NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Antiviral Res", "NlmUniqueID": "8109699", "ISSNLinking": "0166-3542"}, "ChemicalList": [{"RegistryNumber": "98813-13-9", "NameOfSubstance": "bafilomycin D"}, {"RegistryNumber": "0", "NameOfSubstance": "(2S)-N-((2S)-1-(((2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-(methanesulfonamido)pentanediamide)"}, {"RegistryNumber": "EC 3.6.1.-", "NameOfSubstance": "Adenosine Triphosphatases"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Spike Glycoprotein, Coronavirus"}, {"RegistryNumber": "0", "NameOfSubstance": "spike protein, SARS-CoV-2"}], "SupplMeshList": ["SARS-CoV-2 variants"], "CommentsCorrectionsList": [{"RefSource": "Antiviral Res. 2023 May;213:105577. doi: 10.1016/j.antiviral.2023.105577", "PMID": "37002158"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": [], "DescriptorName": "Adenosine Triphosphatases"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": [], "DescriptorName": "Spike Glycoprotein, Coronavirus"}], "CoiStatement": "Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "A living WHO . 2022. A Living WHO Guideline on Drugs for Covid-19. BMJ o1045.", "ArticleIdList": ["10.1136/bmj.o1045", "35470203"]}, {"Citation": "Ashhurst A.S., Tang A.H., Fajtov\u00e1 P., Yoon M.C., Aggarwal A., Bedding M.J., Stoye A., Beretta L., Pwee D., Drelich A., Skinner D., Li L., Meek T.D., McKerrow J.H., Hook V., Tseng C.-T., Larance M., Turville S., Gerwick W.H., O'Donoghue A.J., Payne R.J. Potent anti-SARS-CoV-2 activity by the natural product gallinamide A and analogues via inhibition of cathepsin L. J. Med.Chem.acs. 2021 doi: 10.1021/acs.jmedchem.1c01494. 1c01494.", "ArticleIdList": ["10.1021/acs.jmedchem.1c01494", "PMC8577376", "34730959"]}, {"Citation": "Auth J., Fr\u00f6ba M., Gro\u00dfe M., Rauch P., Ruetalo N., Schindler M., Morokutti-kurz M., Graf P., Dolischka A., Prieschl-grassauer E., Setz C., Schubert U. Lectin from triticum vulgaris (WGA) inhibits infection with SARS-CoV-2 and its variants of concern alpha and beta. Int. J. Mol. Sci. 2021;22 doi: 10.3390/ijms221910205.", "ArticleIdList": ["10.3390/ijms221910205", "PMC8508056", "34638545"]}, {"Citation": "Bao R., Wang S., Yang X., Chen G., Meng X. Phellopterin-induced caspase-dependent apoptosis through PI3K/AKT pathway inhibition in SMMC-7721 human hepatoma cells. Am. J. Pharm. 2018;37:2498\u20132501."}, {"Citation": "Barakat E.M.F., el Wakeel L.M., Hagag R.S. Effects of Nigella sativa on outcome of hepatitis C in Egypt. World J. Gastroenterol. 2013;19:2529\u20132536. doi: 10.3748/wjg.v19.i16.2529.", "ArticleIdList": ["10.3748/wjg.v19.i16.2529", "PMC3646144", "23674855"]}, {"Citation": "Bl\u00e1zquez A.B., Saiz J.C. Zika Virus Impact, Diagnosis, Control, and Models. Elsevier; 2021. Protein kinase C as a target in the control of viruses and implication for Zika virus; pp. 409\u2013415.", "ArticleIdList": ["10.1016/B978-0-12-820267-8.00039-X"]}, {"Citation": "Bowman E.J., Siebers A., Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl. Acad. Sci. USA. 1988;85:7972\u20137976. doi: 10.1073/pnas.85.21.7972.", "ArticleIdList": ["10.1073/pnas.85.21.7972", "PMC282335", "2973058"]}, {"Citation": "Cagno V. SARS-CoV-2 cellular tropism. Lancet Microbe May. 2020:e2\u2013e3. doi: 10.1016/S2666-5247(20)30008-2.", "ArticleIdList": ["10.1016/S2666-5247(20)30008-2", "PMC7173832", "32835319"]}, {"Citation": "Callaway E. Beyond Omicron: what's next for COVID's viral evolution. Nature. 2021;600:204\u2013207. doi: 10.1038/D41586-021-03619-8.", "ArticleIdList": ["10.1038/D41586-021-03619-8", "34876665"]}, {"Citation": "Callaway E. Heavily mutated coronavirus variant puts scientists on alert. Nature. 2021 doi: 10.1038/D41586-021-03552-W.", "ArticleIdList": ["10.1038/D41586-021-03552-W", "34824381"]}, {"Citation": "Callender J.A., Yang Y., Lord\u00e9n G., Stephenson N.L., Jones A.C., Brognard J., Newton A.C. Protein kinase C\u03b1 gain-of-function variant in Alzheimer's disease displays enhanced catalysis by a mechanism that evades down-regulation. Proc. Natl. Acad. Sci. U. S. A. 2018;115:E5497\u2013E5505. doi: 10.1073/PNAS.1805046115/ASSET/CA0D7F9E-61C8-4A0E-9F3C-072EC6F9278E/ASSETS/GRAPHIC/PNAS.1805046115FIG07.JPEG.", "ArticleIdList": ["10.1073/PNAS.1805046115/ASSET/CA0D7F9E-61C8-4A0E-9F3C-072EC6F9278E/ASSETS/GRAPHIC/PNAS.1805046115FIG07.JPEG", "PMC6004447", "29844158"]}, {"Citation": "Carr G., Williams D.E., D\u00edaz-Marrero A.R., Patrick B.O., Bottriell H., Balgi A.D., Donohue E., Roberge M., Andersen R.J. Bafilomycins produced in culture by Streptomyces spp. isolated from marine habitats are potent inhibitors of autophagy. J. Nat. Prod. 2010;73:422\u2013427. doi: 10.1021/np900632r.", "ArticleIdList": ["10.1021/np900632r", "20028134"]}, {"Citation": "Chaipukdee N., Kanokmedhakul K., Kanokmedhakul S., Lekphrom R., Pyne S.G. Two new bioactive iridoids from Rothmannia wittii. Fitoterapia. 2016;113:97\u2013101. doi: 10.1016/J.FITOTE.2016.07.007.", "ArticleIdList": ["10.1016/J.FITOTE.2016.07.007", "27431771"]}, {"Citation": "Chu H., Chan J.F.-W., Yuen T.T.-T., Shuai H., Yuan S., Wang Y., Hu B., Yip C.C.-Y., Tsang J.O.-L., Huang X., Chai Y., Yang D., Hou Y., Chik K.K.-H., Zhang X., Fung A.Y.-F., Tsoi H.-W., Cai J.-P., Chan W.-M., Ip J.D., Chu A.W.-H., Zhou J., Lung D.C., Kok K.-H., To K.K.-W., Tsang O.T.-Y., Chan K.-H., Yuen K.-Y. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study. Lancet Microbe. 2020;1:e14\u2013e23. doi: 10.1016/s2666-5247(20)30004-5.", "ArticleIdList": ["10.1016/s2666-5247(20)30004-5", "PMC7173822", "32835326"]}, {"Citation": "COVID-19  COVID-19 dashboard by the center for systems science and engineering (CSSE) at Johns Hopkins university [WWW document] https://coronavirus.jhu.edu/map.html n.d. URL. 2.8.21."}, {"Citation": "Dampalla C.S., Zheng J., Dinali Perera K., Roy Wong L.-Y., Meyerholz D.K., Nhat Nguyen H., Kashipathy M.M., Battaile K.P., Lovell S., Kim Y., Perlman S., Groutas W.C., Chang K.-O. Proc Natl Acad Sci U S A; 2021. Postinfection Treatment with a Protease Inhibitor Increases Survival of Mice with a Fatal SARS-CoV-2 Infection.", "ArticleIdList": ["10.1073/pnas.2101555118", "PMC8307543", "34210738"]}, {"Citation": "Daniloski Z., Jordan T.X., Wessels H.-H., Hoagland D.A., Kasela S., Legut M., Maniatis S., Mimitou E.P., Lu L., Geller E., Danziger O., Rosenberg B.R., Phatnani H., Smibert P., Lappalainen T., tenOever B.R., Sanjana N.E. Identification of required host factors for SARS-CoV-2 infection in human cells. Cell. 2021;184:92\u2013105. doi: 10.1016/j.cell.2020.10.030. e16.", "ArticleIdList": ["10.1016/j.cell.2020.10.030", "PMC7584921", "33147445"]}, {"Citation": "Daoust J., Chen M., Wang M., Williams D.E., Chavez M.A.G., Wang Y.A., Merchant C.E., Fontana A., Kieffer T.J., Andersen R.J. Sesterterpenoids isolated from a northeastern pacific phorbas sp. J. Org. Chem. 2013;78:8267\u20138273. doi: 10.1021/JO4014589/SUPPL_FILE/JO4014589_SI_001.PDF.", "ArticleIdList": ["10.1021/JO4014589/SUPPL_FILE/JO4014589_SI_001.PDF", "23941043"]}, {"Citation": "Dittmar M., Lee J.S., Whig K., Segrist E., Li M., Kamalia B., Castellana L., Ayyanathan K., Cardenas-Diaz F.L., Morrisey E.E., Truitt R., Yang W., Jurado K., Samby K., Ramage H., Schultz D.C., Cherry S. Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2. Cell Rep. 2021;35 doi: 10.1016/j.celrep.2021.108959.", "ArticleIdList": ["10.1016/j.celrep.2021.108959", "PMC7985926", "33811811"]}, {"Citation": "Fu L., Ye F., Feng Y., Yu F., Wang Q., Wu Y., Zhao C., Sun H., Huang B., Niu P., Song H., Shi Y., Li X., Tan W., Qi J., Gao G.F. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nat. Commun. 2020;11(1):1\u20138. doi: 10.1038/s41467-020-18233-x. 2020 11.", "ArticleIdList": ["10.1038/s41467-020-18233-x", "PMC7474075", "32887884"]}, {"Citation": "Gandhi S., Klein J., Robertson A.J., Pe\u00f1a-Hern\u00e1ndez M.A., Lin M.J., Roychoudhury P., Lu P., Fournier J., Ferguson D., Mohamed Bakhash S.A.K., Catherine Muenker M., Srivathsan A., Wunder E.A., Kerantzas N., Wang W., Lindenbach B., Pyle A., Wilen C.B., Ogbuagu O., Greninger A.L., Iwasaki A., Schulz W.L., Ko A.I. De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report. Nat. Commun. 2022;13(1):1\u20138. doi: 10.1038/s41467-022-29104-y. 2022 13.", "ArticleIdList": ["10.1038/s41467-022-29104-y", "PMC8930970", "35301314"]}, {"Citation": "Gschwendt M., Dieterich S., Rennecke J., Kittstein W., Mueller H.J., Johannes F.J. Inhibition of protein kinase C \u03bc by various inhibitors. Inhibition from protein kinase c isoenzymes. FEBS Lett. 1996;392:77\u201380. doi: 10.1016/0014-5793(96)00785-5.", "ArticleIdList": ["10.1016/0014-5793(96)00785-5", "8772178"]}, {"Citation": "Hacisuleyman E., Hale C., Saito Y., Blachere N.E., Bergh M., Conlon E.G., Schaefer-Babajew D.J., DaSilva J., Muecksch F., Gaebler C., Lifton R., Nussenzweig M.C., Hatziioannou T., Bieniasz P.D., Darnell R.B. Vaccine breakthrough infections with SARS-CoV-2 variants. N. Engl.J.Med.NEJMoa. 2021 doi: 10.1056/NEJMoa2105000.", "ArticleIdList": ["10.1056/NEJMoa2105000", "PMC8117968", "33882219"]}, {"Citation": "Hagen A. n.d. How dangerous is the delta variant (B.1.617.2)? [WWW document] https://asm.org/Articles/2021/July/How-Dangerous-is-the-Delta-Variant-B-1-617-2 URL. 8.29.21."}, {"Citation": "Hampson P., Chahal H., Khanim F., Hayden R., Mulder A., Assi L.K., Bunce C.M., Lord J.M. PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC. Blood. 2005;106:1362\u20131368. doi: 10.1182/BLOOD-2004-10-4117.", "ArticleIdList": ["10.1182/BLOOD-2004-10-4117", "15845901"]}, {"Citation": "Hoffmann Markus, Kleine-Weber H., P\u00f6hlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol. Cell. 2020;78:779\u2013784. doi: 10.1016/j.molcel.2020.04.022. e5.", "ArticleIdList": ["10.1016/j.molcel.2020.04.022", "PMC7194065", "32362314"]}, {"Citation": "Hu Y., Lewandowski E.M., Tan H., Morgan R.T., Zhang X., Jacobs L.M.C., Butler S.G., Mongora M.v., Choy J., Chen Y., Wang J. Naturally occurring mutations of SARS-CoV-2 main protease confer drug resistance to nirmatrelvir. bioRxiv. 2022 doi: 10.1101/2022.06.28.497978. 2022.06.28.", "ArticleIdList": ["10.1101/2022.06.28.497978", "PMC10451032", "37637734"]}, {"Citation": "Huang C., Feng F., Shi Y., Li W., Wang Z., Zhu Y., Yuan S., Hu D., Dai J., Jiang Q., Zhang R., Liu C., Zhang P. Protein kinase C inhibitors reduce SARS-CoV-2 replication in cultured cells. Microbiol. Spectr. 2022 doi: 10.1128/SPECTRUM.01056-22.", "ArticleIdList": ["10.1128/SPECTRUM.01056-22", "PMC9603170", "36000889"]}, {"Citation": "Icho S., Rujas E., Muthuraman K., Tam J., Liang H., Landreth S., Liao M., Falzarano D., Julien J.-P., Melnyk R.A. Dual inhibition of vacuolar-ATPase and TMPRSS2 is required for complete blockade of SARS-CoV-2 entry into cells. Antimicrob. Agents Chemother. 2022;66 doi: 10.1128/aac.00439-22.", "ArticleIdList": ["10.1128/aac.00439-22", "PMC9295568", "35703551"]}, {"Citation": "Indari O., Jakhmola S., Manivannan E., Jha H.C. An update on antiviral therapy against SARS-CoV-2: how far have we come? Front. Pharmacol. 2021:133. doi: 10.3389/FPHAR.2021.632677. 0.", "ArticleIdList": ["10.3389/FPHAR.2021.632677", "PMC7982669", "33762954"]}, {"Citation": "Jochmans D., Liu C., Donckers K., Stoycheva A., Boland S., Stevens S.K., de Vita C., Vanmechelen B., Maes P., Tr\u00fceb B., Ebert N., Thiel V., de Jonghe S., Vangeel L., Bardiot D., Jekle A., Blatt L.M., Beigelman L., Symons J.A., Raboisson P., Chaltin P., Marchand A., Neyts J., Deval J., Vandyck K. bioRxiv; 2022. The Substitutions L50F, E166A and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor in Vitro and Confer Resistance to Nirmatrelvir. 2022.06.07.495116.", "ArticleIdList": ["10.1101/2022.06.07.495116", "PMC9973015", "36625640"]}, {"Citation": "Kawano T., Inokuchi J., Eto M., Murata M., Kang J.H. Activators and inhibitors of protein kinase C (PKC): their applications in clinical trials. Pharmaceutics. 2021;13 doi: 10.3390/PHARMACEUTICS13111748.", "ArticleIdList": ["10.3390/PHARMACEUTICS13111748", "PMC8621927", "34834162"]}, {"Citation": "Kedei N., Lundberg D.J., Toth A., Welburn P., Garfield S.H., Blumberg P.M. Characterization of the interaction of ingenol 3-angelate with protein kinase C. Cancer Res. 2004;64:3243\u20133255. doi: 10.1158/0008-5472.CAN-03-3403.", "ArticleIdList": ["10.1158/0008-5472.CAN-03-3403", "15126366"]}, {"Citation": "Khumkomkhet P., Kanokmedhakul S., Kanokmedhakul K., Hahnvajanawong C., Soytong K. Antimalarial and cytotoxic depsidones from the fungus Chaetomium brasiliense. J. Nat. Prod. 2009;72:1487\u20131491. doi: 10.1021/np9003189.", "ArticleIdList": ["10.1021/np9003189", "19663417"]}, {"Citation": "Kj\u00e6r S., Linch M., Purkiss A., Kostelecky B., Knowles P.P., Rosse C., Riou P., Soudy C., Kaye S., Patel B., Soriano E., Murray-Rust J., Barton C., Dillon C., Roffey J., Parker P.J., McDonald N.Q. Adenosine-binding motif mimicry and cellular effects of a thieno[2,3- d ]pyrimidine-based chemical inhibitor of atypical protein kinase C isoenzymes. Biochem. J. 2013;451:329\u2013342. doi: 10.1042/BJ20121871.", "ArticleIdList": ["10.1042/BJ20121871", "23418854"]}, {"Citation": "Koivunen J., Aaltonen V., Koskela S., Lehenkari P., Laato M., Peltonen J. Protein kinase C \u03b1/\u03b2 inhibitor Go6976 promotes formation of cell junctions and inhibits invasion of urinary bladder carcinoma cells. Cancer Res. 2004;64:5693\u20135701. doi: 10.1158/0008-5472.CAN-03-3511.", "ArticleIdList": ["10.1158/0008-5472.CAN-03-3511", "15313909"]}, {"Citation": "Kretschmer A., Dorgerloh M., Deeg M., Hagenmaier H. The structures of novel insecticidal macrolides: bafilomycins D and E, and oxohygrolidin. Agric. Biol. Chem. 1985;49:2509\u20132511. doi: 10.1271/bbb1961.49.2509.", "ArticleIdList": ["10.1271/bbb1961.49.2509"]}, {"Citation": "Kreutzberger A.J.B., Sanyal A., Ojha R., Pyle J.D., Vapalahti O., Balistreri G., Kirchhausen T. Synergistic block of SARS-CoV-2 infection by combined drug inhibition of the host entry factors PIKfyve kinase and TMPRSS2 protease. J. Virol. 2021;95 doi: 10.1128/JVI.00975-21.", "ArticleIdList": ["10.1128/JVI.00975-21", "PMC8513479", "34406858"]}, {"Citation": "Li M., Lou F., Fan H. SARS-CoV-2 Variants of Concern Delta: a great challenge to prevention and control of COVID-19. Signal Transduct. Targeted Ther. 2021;6(1 6):1\u20133. doi: 10.1038/s41392-021-00767-1. 2021.", "ArticleIdList": ["10.1038/s41392-021-00767-1", "PMC8475295", "34580279"]}, {"Citation": "Li P., Wang Y., Lavrijsen M., Lamers M.M., de Vries A.C., Rottier R.J., Bruno M.J., Peppelenbosch M.P., Haagmans B.L., Pan Q. SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination. Cell Res. 2022;32(3 32):322\u2013324. doi: 10.1038/s41422-022-00618-w. 2022.", "ArticleIdList": ["10.1038/s41422-022-00618-w", "PMC8771185", "35058606"]}, {"Citation": "Linch M., Sanz-Garcia M., Rosse C., Riou P., Peel N., Madsen C.D., Sahai E., Downward J., Khwaja A., Dillon C., Roffey J., Cameron A.J.M., Parker P.J. Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids. Carcinogenesis. 2014;35:396\u2013406. doi: 10.1093/carcin/bgt313.", "ArticleIdList": ["10.1093/carcin/bgt313", "PMC3908745", "24072773"]}, {"Citation": "Ma R.C.W., Tam C.H.T., Wang Y., Luk A.O., Hu C., Yang X., Lam V., Chan A.W.H., Ho J.S.K., Chow C.C., Tong P.C.Y., Jia W., Ng M.C.Y., So W.Y., Chan J.C.N. Genetic variants of the protein kinase C-beta 1 gene and development of end-stage renal disease in patients with type 2 diabetes. JAMA. 2010;304:881\u2013889. doi: 10.1001/JAMA.2010.1191.", "ArticleIdList": ["10.1001/JAMA.2010.1191", "20736472"]}, {"Citation": "Mani J.S., Johnson J.B., Steel J.C., Broszczak D.A., Neilsen P.M., Walsh K.B., Naiker M. 2020. Natural Product-Derived Phytochemicals as Potential Agents against Coronaviruses: A Review.", "ArticleIdList": ["10.1016/j.virusres.2020.197989", "PMC7190535", "32360300"]}, {"Citation": "McKee M., Stuckler D. If the world fails to protect the economy, COVID-19 will damage health not just now but also in the future. Nat. Med. 2020 doi: 10.1038/s41591-020-0863-y.", "ArticleIdList": ["10.1038/s41591-020-0863-y", "32273610"]}, {"Citation": "Meganck R.M., Baric R.S. Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases. Nat. Med. 2021;27:401\u2013410. doi: 10.1038/s41591-021-01282-0.", "ArticleIdList": ["10.1038/s41591-021-01282-0", "33723456"]}, {"Citation": "Moghadamtousi S.Z., Nikzad S., Kadir H.A., Abubakar S., Zandi K. Potential antiviral agents from marine fungi: an overview. Mar. Drugs. 2015;13:4520\u20134538. doi: 10.3390/MD13074520.", "ArticleIdList": ["10.3390/MD13074520", "PMC4515631", "26204947"]}, {"Citation": "Moradpour D., Evans M.J., Gosert R., Yuan Z., Blum H.E., Goff S.P., Lindenbach B.D., Rice C.M. Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes. J. Virol. 2004;78:7400\u20137409. doi: 10.1128/JVI.78.14.7400-7409.2004/FORMAT/EPUB.", "ArticleIdList": ["10.1128/JVI.78.14.7400-7409.2004/FORMAT/EPUB", "PMC434129", "15220413"]}, {"Citation": "Muller P.Y., Milton M.N. The determination and interpretation of the therapeutic index in drug development. Nat. Rev. Drug Discov. 2012;11(10):751\u2013761. doi: 10.1038/nrd3801. 2012 11.", "ArticleIdList": ["10.1038/nrd3801", "22935759"]}, {"Citation": "Musarra-Pizzo M., Pennisi R., Ben-Amor I., Mandalari G., Sciortino M.T. Antiviral activity exerted by natural products against human viruses. Viruses. 2021;13 doi: 10.3390/V13050828.", "ArticleIdList": ["10.3390/V13050828", "PMC8147851", "34064347"]}, {"Citation": "Ogando N.S., Dalebout T.J., Zevenhoven-Dobbe J.C., Limpens R.W.A.L., van der Meer Y., Caly L., Druce J., de Vries J.J.C., Kikkert M., Barcena M., Sidorov I., Snijder E.J. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. J. Gen. Virol. 2020;101:925. doi: 10.1099/JGV.0.001453.", "ArticleIdList": ["10.1099/JGV.0.001453", "PMC7654748", "32568027"]}, {"Citation": "Olmstead A.D., Knecht W., Lazarov I., Dixit S.B., Jean F. Human subtilase SKI-1/S1P is a master regulator of the HCV lifecycle and a potential host cell target for developing indirect-acting antiviral agents. PLoS Pathog. 2012;8 doi: 10.1371/journal.ppat.1002468.", "ArticleIdList": ["10.1371/journal.ppat.1002468", "PMC3252376", "22241994"]}, {"Citation": "Planas D., Saunders N., Maes P., Guivel-Benhassine F., Planchais C., Buchrieser J., Bolland W.-H., Porrot F., Staropoli I., Lemoine F., P\u00e9r\u00e9 H., Veyer D., Puech J., Rodary J., Baele G., Dellicour S., Raymenants J., Gorissen S., Geenen C., Vanmechelen B., Wawina -Bokalanga T., Mart\u00ed-Carreras J., Cuypers L., S\u00e8ve A., Hocqueloux L., Prazuck T., Rey F., Simon-Loriere E., Bruel T., Mouquet H., Andr\u00e9 E., Schwartz O. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2021:1\u20137. doi: 10.1038/s41586-021-04389-z. 2021.", "ArticleIdList": ["10.1038/s41586-021-04389-z", "35016199"]}, {"Citation": "Ranganath N., O'Horo J.C., Challener D.W., Tulledge-Scheitel S.M., Pike M.L., Michael O'Brien R., Razonable R.R., Shah A. Rebound phenomenon after nirmatrelvir/ritonavir treatment of coronavirus disease-2019 in high-risk persons. Clin. Infect. Dis. 2022 doi: 10.1093/CID/CIAC481.", "ArticleIdList": ["10.1093/CID/CIAC481", "PMC9384250", "35698452"]}, {"Citation": "Rockett R.J., Draper J., Gall M., Sim E.M., Arnott A., Agius J.E., Johnson-Mackinnon J., Fong W., Martinez E., Drew A.P., Lee C., Ngo C., Ramsperger M., Ginn A.N., Wang Q., Fennell M., Ko D., Hueston L., Kairaitis L., Holmes E.C., O'Sullivan M.N., Chen S.C.-A., Kok J., Dwyer D.E., Sintchenko V. Co-infection with SARS-CoV-2 Omicron and Delta variants revealed by genomic surveillance. Nat. Commun. 2022;13(1):1\u20137. doi: 10.1038/s41467-022-30518-x. 2022 13.", "ArticleIdList": ["10.1038/s41467-022-30518-x", "PMC9117272", "35585202"]}, {"Citation": "SARS  SARS-CoV-2 variants of concern | CDC [WWW document] https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-surveillance/variant-info.html n.d. URL. 2.8.21."}, {"Citation": "Sayed A.M., Alhadrami H.A., El-Gendy A.O., Shamikh Y.I., Belbahri L., Hassan H.M., Abdelmohsen U.R., Rateb M.E. Microbial natural products as potential inhibitors of SARS-CoV-2 main protease (Mpro) Microorganisms. 2020;8:1\u201317. doi: 10.3390/microorganisms8070970.", "ArticleIdList": ["10.3390/microorganisms8070970", "PMC7409236", "32610445"]}, {"Citation": "Schultz D.C., Johnson R.M., Ayyanathan K., Miller J., Whig K., Kamalia B., Dittmar M., Weston S., Hammond H.L., Dillen C., Ardanuy J., Taylor L., Lee J.S., Li M., Lee E., Shoffler C., Petucci C., Constant S., Ferrer M., Thaiss C.A., Frieman M.B., Cherry S. Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2. Nature. 2022;604(7904):134\u2013140. doi: 10.1038/s41586-022-04482-x. 2022 604.", "ArticleIdList": ["10.1038/s41586-022-04482-x", "PMC10377386", "35130559"]}, {"Citation": "Shagufta, Ahmad I. The race to treat COVID-19: potential therapeutic agents for the prevention and treatment of SARS-CoV-2. Eur. J. Med. Chem. 2021;213 doi: 10.1016/j.ejmech.2021.113157.", "ArticleIdList": ["10.1016/j.ejmech.2021.113157", "PMC7802596", "33486200"]}, {"Citation": "Shapira T., Monreal I.A., Dion S.P., Buchholz D.W., Imbiakha B., Olmstead A.D., Jager M., D\u00e9silets A., Gao G., Martins M., Vandal T., Thompson C.A.H., Chin A., Rees W.D., Steiner T., Nabi I.R., Marsault E., Sahler J., Diel D.G., van de Walle G.R., August A., Whittaker G.R., Boudreault P.-L., Leduc R., Aguilar H.C., Jean F. A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. Nature. 2022 doi: 10.1038/s41586-022-04661-w.", "ArticleIdList": ["10.1038/s41586-022-04661-w", "PMC9095466", "35344983"]}, {"Citation": "Shyr Z.A., Cheng Y.S., Lo D.C., Zheng W. Drug combination therapy for emerging viral diseases. Drug Discov. Today. 2021;26:2367. doi: 10.1016/J.DRUDIS.2021.05.008.", "ArticleIdList": ["10.1016/J.DRUDIS.2021.05.008", "PMC8139175", "34023496"]}, {"Citation": "Sievers B.L., Chakraborty S., Xue Y., Gelbart T., Gonzalez J.C., Cassidy A.G., Golan Y., Prahl M., Gaw S.L., Arunachalam P.S., Blish C.A., Boyd S.D., Davis M.M., Jagannathan P., Nadeau K.C., Pulendran B., Singh U., Scheuermann R.H., Frieman M.B., Vashee S., Wang T.T., Tan G.S. Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses. Sci. Transl. Med. 2022 doi: 10.1126/SCITRANSLMED.ABN7842.", "ArticleIdList": ["10.1126/SCITRANSLMED.ABN7842", "PMC8891085", "35025672"]}, {"Citation": "Sun M.-K., Alkon D.L. Bryostatin-1: pharmacology and therapeutic potential as a CNS drug. CNS Drug Rev. 2006;12:1\u20138. doi: 10.1111/j.1527-3458.2006.00001.x.", "ArticleIdList": ["10.1111/j.1527-3458.2006.00001.x", "PMC6741713", "16834754"]}, {"Citation": "Szemiel A.M., Merits A., Orton R.J., MacLean O.A., Pinto R.M., Wickenhagen A., Lieber G., Turnbull M.L., Wang S., Furnon W., Suarez N.M., Mair D., da Silva Filipe A., Willett B.J., Wilson S.J., Patel A.H., Thomson E.C., Palmarini M., Kohl A., Stewart M.E. In vitro selection of Remdesivir resistance suggests evolutionary predictability of SARS-CoV-2. PLoS Pathog. 2021;17 doi: 10.1371/JOURNAL.PPAT.1009929.", "ArticleIdList": ["10.1371/JOURNAL.PPAT.1009929", "PMC8496873", "34534263"]}, {"Citation": "Takashita E., Yamayoshi S., Simon V., van Bakel H., Sordillo E.M., Pekosz A., Fukushi S., Suzuki T., Maeda K., Halfmann P., Sakai-Tagawa Y., Ito M., Watanabe S., Imai M., Hasegawa H., Kawaoka Y. Efficacy of antibodies and antiviral drugs against omicron BA.2.12.1, BA.4, and BA.5 subvariants. N. Engl. J. Med. 2022;387:468\u2013470. doi: 10.1056/NEJMc2207519.", "ArticleIdList": ["10.1056/NEJMc2207519", "PMC9342381", "35857646"]}, {"Citation": "Tang J., Wennerberg K., Aittokallio T. What is synergy? The Saariselk\u00e4 agreement revisited. Front. Pharmacol. 2015;6 doi: 10.3389/fphar.2015.00181.", "ArticleIdList": ["10.3389/fphar.2015.00181", "PMC4555011", "26388771"]}, {"Citation": "Tao S., Zandi K., Bassit L., Ong Y.T., Verma K., Liu P., Downs-Bowen J.A., McBrayer T., LeCher J.C., Kohler J.J., Tedbury P.R., Kim B., Amblard F., Sarafianos S.G., Schinazi R.F. Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside. Curr. Res.Pharmacol. Drug Discov. 2021;2 doi: 10.1016/j.crphar.2021.100045.", "ArticleIdList": ["10.1016/j.crphar.2021.100045", "PMC8357487", "34870151"]}, {"Citation": "United States  . 2022. United States - COVID-19 Overview - Johns Hopkins [WWW Document]https://coronavirus.jhu.edu/region/united-states URL. 5.12.22."}, {"Citation": "Wang M., Sciorillo A., Read S., Divsalar D.N., Gyampoh K., Zu G., Yuan Z., Mounzer K., Williams D.E., Montaner L.J., de Voogd N., Tietjen I., Andersen R.J. Ansellone J, a potent in vitro and ex vivo HIV-1 latency reversal agent isolated from a phorbas sp. marine sponge. J. Nat. Prod. 2022;85:1274\u20131281. doi: 10.1021/ACS.JNATPROD.1C01225.", "ArticleIdList": ["10.1021/ACS.JNATPROD.1C01225", "35522580"]}, {"Citation": "Wang M., Tietjen I., Chen M., Williams D.E., Daoust J., Brockman M.A., Andersen R.J. Sesterterpenoids isolated from the sponge phorbas sp. activate latent HIV-1 provirus expression. J. Org. Chem. 2016;81:11324\u201311334. doi: 10.1021/ACS.JOC.6B02312/ASSET/IMAGES/LARGE/JO-2016-02312B_0005.JPEG.", "ArticleIdList": ["10.1021/ACS.JOC.6B02312/ASSET/IMAGES/LARGE/JO-2016-02312B_0005.JPEG", "27768313"]}, {"Citation": "Wang S.X., Zhang X.S., Guan H.S., Wang W. Potential anti-HPV and related cancer agents from marine resources: an overview. Mar. Drugs. 2014;12:2019\u20132035. doi: 10.3390/MD12042019.", "ArticleIdList": ["10.3390/MD12042019", "PMC4012449", "24705500"]}, {"Citation": "Wang Z., Yang L. Turning the tide: natural products and natural-product-inspired chemicals as potential counters to SARS-CoV-2 infection. Front. Pharmacol. 2020 doi: 10.3389/fphar.2020.01013.", "ArticleIdList": ["10.3389/fphar.2020.01013", "PMC7343773", "32714193"]}, {"Citation": "Williams D.E., Bernan V.S., Ritacco F. v, Maiese W.M., Greenstein M., Andersen R.J. Holyrines A and B, possible intermediates in staurosporine biosynthesis produced in culture by a marine actinomycete obtained from the North Atlantic Ocean. Tetrahedron Lett. 1999;40:7171\u20137174."}, {"Citation": "Wu C.-J., Cui X., Xiong B., Yang M.-S., Zhang Y.-X., Liu X.-M. Terretonin D1, a new meroterpenoid from marine-derived Aspergillus\u00ef\u00bf\u00bfterreus ML-44. Nat. Prod. Res. 2019;33:2262\u20132265. doi: 10.1080/14786419.2018.1493583.", "ArticleIdList": ["10.1080/14786419.2018.1493583", "30394102"]}, {"Citation": "Xiao F., Zimpelmann J., Burger D., Kennedy C., H\u00e9bert R.L., Burns K.D. Protein kinase C-\u03b4 mediates shedding of angiotensin-converting enzyme 2 from proximal tubular cells. Front. Pharmacol. 2016;7 doi: 10.3389/FPHAR.2016.00146.", "ArticleIdList": ["10.3389/FPHAR.2016.00146", "PMC4887483", "27313531"]}, {"Citation": "Xie X., Muruato A., Lokugamage K.G., Narayanan K., Zhang X., Zou J., Liu J., Schindewolf C., Bopp N.E., Aguilar P.v., Plante K.S., Weaver S.C., Makino S., LeDuc J.W., Menachery V.D., Shi P.Y. An infectious cDNA clone of SARS-CoV-2. Cell Host Microbe. 2020;27:841\u2013848. doi: 10.1016/j.chom.2020.04.004. e3.", "ArticleIdList": ["10.1016/j.chom.2020.04.004", "PMC7153529", "32289263"]}, {"Citation": "Yadav B., Wennerberg K., Aittokallio T., Tang J. Searching for drug synergy in complex dose\u2013response landscapes using an interaction potency model. Comput. Struct. Biotechnol. J. 2015;13:504\u2013513. doi: 10.1016/j.csbj.2015.09.001.", "ArticleIdList": ["10.1016/j.csbj.2015.09.001", "PMC4759128", "26949479"]}, {"Citation": "Zhang J.-H., Chung T.D.Y., Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays | enhanced reader [WWW document] J. Biomol. Screen. 1999 doi: 10.1177/108705719900400206.", "ArticleIdList": ["10.1177/108705719900400206", "10838414"]}, {"Citation": "Zhao H., Lu L., Peng Z., Chen L.L., Meng X., Zhang C., Ip J.D., Chan W.M., Chu A.W.H., Chan K.H., Jin D.Y., Chen H., Yuen K.Y., To K.K.W. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerg. Microb. Infect. 2022;11:277\u2013283. doi: 10.1080/22221751.2021.2023329.", "ArticleIdList": ["10.1080/22221751.2021.2023329", "PMC8774049", "34951565"]}, {"Citation": "Zheng S., Wang W., Aldahdooh J., Malyutina A., Shadbahr T., Tanoli Z., Pessia A., Tang J. SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets. Dev. Reprod. Biol. 2022 doi: 10.1016/j.gpb.2022.01.004.", "ArticleIdList": ["10.1016/j.gpb.2022.01.004", "PMC9801064", "35085776"]}, {"Citation": "Zhu Yunkai, Feng F., Hu G., Wang Y., Yu Y., Zhu Yuanfei, Xu W., Cai X., Sun Z., Han W., Ye R., Qu D., Ding Q., Huang X., Chen H., Xu W., Xie Y., Cai Q., Yuan Z., Zhang R. A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry. Nat. Commun. 2021;12:961. doi: 10.1038/s41467-021-21213-4.", "ArticleIdList": ["10.1038/s41467-021-21213-4", "PMC7878750", "33574281"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "10", "Day": "18"}, {"Year": "2022", "Month": "11", "Day": "26"}, {"Year": "2022", "Month": "12", "Day": "7"}, {"Year": "2022", "Month": "12", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "1", "Day": "18", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "12", "Day": "12", "Hour": "8", "Minute": "58"}, {"Year": "2022", "Month": "12", "Day": "8"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36503013", "PMC9729583", "10.1016/j.antiviral.2022.105484", "S0166-3542(22)00253-4"]}}], "PubmedBookArticle": []}